BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 873734)

  • 1. Castration effects on tumor specific immunity.
    Brannen GE; Gomolka DM; Wettlaufer JN; Modarelli RO
    Invest Urol; 1977 Jul; 15(1):28-38. PubMed ID: 873734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Castration effects on tumor-specific immunity.
    Brannen GE
    Natl Cancer Inst Monogr; 1978 Dec; (49):101-4. PubMed ID: 748764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current topics on tumor immunology].
    Tachibana T
    Gan No Rinsho; 1983 Oct; 29(13):1492-8. PubMed ID: 6608013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
    Zbar B; Manohar V; Sugimoto T; Ashley MP; Kato Y; Rappaport P
    Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro studies of the influence of the immune status of C3Hf-Bu mice on the effectiveness of local irradiation of a methylcholanthrene-induced fibrosarcoma.
    Jurin M; Suit HD
    Cancer Res; 1972 Oct; 32(10):2201-11. PubMed ID: 5080765
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of heightened tumor immunity induced by cryosurgery.
    Faraci RP; Bagley DH; Marrone JC; Ketcham AS; Beazley RM
    Am Surg; 1975 May; 41(5):309-11. PubMed ID: 1130764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M; Suit HD
    Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
    [No Abstract]   [Full Text] [Related]  

  • 8. The specificity of concomitant tumor immunity at large tumor volumes.
    Deckers PJ; Pardridge DH; Wang BS; Mannick JA
    Cancer Res; 1976 Oct; 36(10):3690-4. PubMed ID: 953994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant immunity and specific desensitization in murine tumor hosts.
    Vaage J
    Isr J Med Sci; 1973 Mar; 9(3):332-43. PubMed ID: 4710041
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune responses to soluble tumor antigens in various stages of tumor growth.
    Brannen GE; Santos GW
    Invest Urol; 1975 Sep; 13(2):79-84. PubMed ID: 1184342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice.
    Vaage J
    Cancer Res; 1972 Feb; 32(2):193-9. PubMed ID: 5058179
    [No Abstract]   [Full Text] [Related]  

  • 12. Protective immunity to progressive tumors can be induced by antigen presented on regressor tumors.
    Flood PM; Schreiber H; Ron Y
    J Immunol; 1987 May; 138(10):3573-9. PubMed ID: 3571978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice.
    Rios A; Simmons RL
    Cancer Res; 1972 Jan; 32(1):16-21. PubMed ID: 4550256
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of tumor size on concomitant tumor immunity.
    Deckers PJ; Davis RC; Parker GA; Mannick JA
    Cancer Res; 1973 Jan; 33(1):33-9. PubMed ID: 4682321
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigenicity of cells derived from mouse prostate cells after malignant transformation in vitro by carcinogenic hydrocarbons.
    Mondal S; Iype PT; Griesbach LM; Heidelberger C
    Cancer Res; 1970 Jun; 30(6):1593-7. PubMed ID: 5457933
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of protective immunity against bacterial and viral infections in tumor-bearing mice coincident with suppression of tumor immunity.
    Bonventre PF; Nickol AD; Ball EJ; Michael JG; Bubel HC
    J Reticuloendothel Soc; 1982 Jul; 32(1):25-35. PubMed ID: 6290658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of different cancer treatment methods on immunity to an antigenic transplantable murine fibrosarcoma (Meth A).
    Khafagy M; Wanebo HJ; Alfieri A; Hahn EW
    AJR Am J Roentgenol; 1977 Jun; 128(6):1027-9. PubMed ID: 414534
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro.
    Tomazic VJ; Farha M; Loftus A; Elias EG
    J Immunol; 1988 Jun; 140(11):4056-61. PubMed ID: 3372997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumor immunity induced by local radiotherapy].
    Yamashita T; Hayakawa Y; Hanajima K; Mochizuki S
    Gan No Rinsho; 1983 Oct; 29(13):1506-11. PubMed ID: 6422094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cytomegalovirus infection on the growth of murine fibrosarcomas--evidence for two separate host defense mechanisms against tumors.
    Lannin DR; Howard RJ; Yu S; Collins AL; McKhann CF
    Surg Forum; 1979; 30():145-7. PubMed ID: 231846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.